Doxepin Hydrochloride NDC 62135-563

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-563Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0563Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-563-90	62135056390	90 CAPSULE in 1 BOTTLE (62135-563-90)Marketed from Nov 22, 2022 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxepin Hydrochloride
Generic name (nonproprietary): doxepin hydrochloride
Active ingredients: Doxepin hydrochloride — 75 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210268
Marketing start: Sep 4, 2020
Listing expires: Dec 31, 2026
Identifiers: Product ID 62135-563_459bacaf-9b0a-6657-e063-6394a90a66cfSPL ID 459bacaf-9b0a-6657-e063-6394a90a66cfSPL set ID 33a15c3f-bec0-4703-a4e9-f8f78f8b5fd3RxCUI 1000048, 1000058, 1000070, 1000076, 1000097UNII 3U9A0FE9N5UPC 0362135561901, 0362135562908, 0362135564902, 0362135560904, 0362135563905
Pharmacologic class: Tricyclic Antidepressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135056390 followed by a unit qualifier and the quantity

Package 62135-0563-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 10, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Doxepin hydrochloride capsules are recommended for the treatment of: Psychoneurotic patients with depression and/or anxiety. Depression and/or anxiety associated with alcoholism (not to be taken concomitantly with alcohol). Depression and/or anxiety associated with organic disease (the possibility of drug interaction should be considered if the patient is receiving other drugs concomitantly). Psychotic depressive disorders with associated anxiety including involutional depression and manic-depressive disorders. The target symptoms of psychoneurosis that respond particularly well to doxepin include anxiety, tension, depression, somatic symptoms and concerns, sleep distur…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210268

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210268
Product	Strength	Form · route	Labeler	Product NDC
Doxepin Hydrochloride	Doxepin hydrochloride 10 mg/1	CapsuleOral	Chartwell RX, LLC	62135-560
Doxepin Hydrochloride	Doxepin hydrochloride 25 mg/1	CapsuleOral	Chartwell RX, LLC	62135-561
Doxepin Hydrochloride	Doxepin hydrochloride 50 mg/1	CapsuleOral	Chartwell RX, LLC	62135-562
Doxepin Hydrochloride	Doxepin hydrochloride 100 mg/1	CapsuleOral	Chartwell RX, LLC	62135-564